Cover Image
Market Research Report - 249397

The United States Rheumatic Diseases Therapeutics Market

Published by Frost & Sullivan
Published Content info 121 Pages
Price
Back to Top
The United States Rheumatic Diseases Therapeutics Market
Published: August 28, 2012 Content info: 121 Pages
Description

Abstract

Changes on the Horizon with Novel Oral Therapies for Musculoskeletal Indications

This research service covers the therapeutics for rheumatic diseases market in the United States from 2009 to 2017, with 2011 as the base year. The focus of this research is on biologics and other treatments prescribed as add-on therapies for rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS); background standard of care therapies are not covered in this study. Included in the study are products already on the market and products in development as well as patient and revenue forecasts. Market challenges, drivers, and restraints are identified and assessed. The market is segmented by disease indication: RA, PsA, and AS.

Key Questions This Study Will Answer

  • Is the market growing, how long will it continue to grow, and at what rate?
  • Is this a consolidated or diverse market? How will the structure evolve?
  • What are the unmet needs? How can emerging competitors meet these needs?
  • How will new agents fit into the treatment paradigm?
  • What are the major trends affecting the growth of this market? What are the risks for participants or potential participants?
Table of Contents

Table of Contents

1. Rheumatic Diseases Therapeutics Market

Analysis of the United States Rheumatic Diseases Therapeutics Market

  • Executive Summary and Market Overview

2. Rheumatic Diseases Therapeutics Market - Total Market

Analysis of the Total Rheumatic Diseases Therapeutics Market

  • Drivers and Restraints
  • Forecasts and Trends
  • Demand Analysis
  • Market Share and Competitive Analysis

3. Rheumatoid Arthritis Segment

Analysis of the Rheumatoid Arthritis Segment

  • Segment Breakdown and Market Engineering Measurements
  • Patient Forecast
  • Pricing Trends and Forecast
  • Revenue Forecast
  • Market Share Analysis

4. Psoriatic Arthritis Segment

Analysis of the Psoriatic Arthritis Segment

  • Segment Breakdown and Market Engineering Measurements
  • Patient Forecast
  • Pricing Trends and Forecast
  • Revenue Forecast
  • Market Share Analysis

5. Ankylosing Spondylitis Segment

Analysis of the Ankylosing Spondylitis Segment

  • Segment Breakdown and Market Engineering Measurements
  • Patient Forecast
  • Pricing Trends and Forecast
  • Revenue Forecast
  • Market Share Analysis

6. The Last Word

The Last Word

  • Summary and Conclusions

7. Appendix

Appendix

  • Appendix
Back to Top